Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
B.1.177.87ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.87ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.87ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.87NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.39.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.39.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.39.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-15680China
FL.39.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
BA.5.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.4.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.4.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.4.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.73 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.73 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.73 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.73 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.60 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.60 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.60 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.60 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.124.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.124.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.124.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.124.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GS.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GS.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.13.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.13.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XYORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XYENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XYENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XYNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used